Temporal summation of second pain |
Exacerbated (QST) |
Pain threshold (cold or heat) |
Decreased (QST) - particularly heat pain |
Pain tolerance (cold or heat) |
Decreased (QST) |
Supra-threshold stimulation |
Decreased duration of tolerance (QST) |
Average opioid dose |
≥ 75 mg daily morphine equivalent dose |
Duration of opioid therapy |
≥ 3 months |
Opioid dose escalation |
Limited improvement or normalization on QST responses |
Opioid dose reduction |
Improved opioid analgesia [38] |
Pain quality |
Burning, diffuse pain, and spontaneous pain similar to those seen with neuropathic pain |
Pain location |
At and/or beyond the dermatome distribution of a pre-existing pain condition |
Pain intensity |
Similar or greater than pre-existing pain |
Opioid type to be considered |
Short-acting vs. long acting; methadone versus other opioid analgesics |
Gender |
Female vs. male? |